img

Global Digital Companion Diagnostics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Digital Companion Diagnostics Market Insights, Forecast to 2034

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on.
Market Analysis and InsightsGlobal Digital Companion Diagnostics Market
Global Digital Companion Diagnostics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Digital Companion Diagnostics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Digital Companion Diagnostics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Digital Companion Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Myriad Genetic Laboratories, Inc.
Qiagen Manchester, Ltd.
Roche
Dako North America
Abbott
ICON plc
Illumina, Inc
Thermo Fisher
Segment by Type
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)

Segment by Application


Breast Cancer
Melanoma
Lung Cancer
Colorectal Cancer
Infectious Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Digital Companion Diagnostics introduction, etc. Digital Companion Diagnostics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Digital Companion Diagnostics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Digital Companion Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Breast Cancer
1.3.3 Melanoma
1.3.4 Lung Cancer
1.3.5 Colorectal Cancer
1.3.6 Infectious Disease
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Companion Diagnostics Market Perspective (2018-2033)
2.2 Global Digital Companion Diagnostics Growth Trends by Region
2.2.1 Digital Companion Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Digital Companion Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Digital Companion Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Digital Companion Diagnostics Market Dynamics
2.3.1 Digital Companion Diagnostics Industry Trends
2.3.2 Digital Companion Diagnostics Market Drivers
2.3.3 Digital Companion Diagnostics Market Challenges
2.3.4 Digital Companion Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Digital Companion Diagnostics by Players
3.1.1 Global Digital Companion Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Digital Companion Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Digital Companion Diagnostics Market Concentration Ratio
3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2022
3.5 Global Key Players of Digital Companion Diagnostics Head office and Area Served
3.6 Global Key Players of Digital Companion Diagnostics, Product and Application
3.7 Global Key Players of Digital Companion Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Companion Diagnostics Breakdown Data by Type
4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2024-2033)
5 Digital Companion Diagnostics Breakdown Data by Application
5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Digital Companion Diagnostics Market Size (2018-2033)
6.2 North America Digital Companion Diagnostics Market Size by Type
6.2.1 North America Digital Companion Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Digital Companion Diagnostics Market Size by Type (2024-2033)
6.2.3 North America Digital Companion Diagnostics Market Share by Type (2018-2033)
6.3 North America Digital Companion Diagnostics Market Size by Application
6.3.1 North America Digital Companion Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Digital Companion Diagnostics Market Size by Application (2024-2033)
6.3.3 North America Digital Companion Diagnostics Market Share by Application (2018-2033)
6.4 North America Digital Companion Diagnostics Market Size by Country
6.4.1 North America Digital Companion Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Digital Companion Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Digital Companion Diagnostics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Digital Companion Diagnostics Market Size (2018-2033)
7.2 Europe Digital Companion Diagnostics Market Size by Type
7.2.1 Europe Digital Companion Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Digital Companion Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe Digital Companion Diagnostics Market Share by Type (2018-2033)
7.3 Europe Digital Companion Diagnostics Market Size by Application
7.3.1 Europe Digital Companion Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Digital Companion Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe Digital Companion Diagnostics Market Share by Application (2018-2033)
7.4 Europe Digital Companion Diagnostics Market Size by Country
7.4.1 Europe Digital Companion Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Digital Companion Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Digital Companion Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Digital Companion Diagnostics Market Size (2018-2033)
8.2 China Digital Companion Diagnostics Market Size by Type
8.2.1 China Digital Companion Diagnostics Market Size by Type (2018-2023)
8.2.2 China Digital Companion Diagnostics Market Size by Type (2024-2033)
8.2.3 China Digital Companion Diagnostics Market Share by Type (2018-2033)
8.3 China Digital Companion Diagnostics Market Size by Application
8.3.1 China Digital Companion Diagnostics Market Size by Application (2018-2023)
8.3.2 China Digital Companion Diagnostics Market Size by Application (2024-2033)
8.3.3 China Digital Companion Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Digital Companion Diagnostics Market Size (2018-2033)
9.2 Asia Digital Companion Diagnostics Market Size by Type
9.2.1 Asia Digital Companion Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Digital Companion Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia Digital Companion Diagnostics Market Share by Type (2018-2033)
9.3 Asia Digital Companion Diagnostics Market Size by Application
9.3.1 Asia Digital Companion Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Digital Companion Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia Digital Companion Diagnostics Market Share by Application (2018-2033)
9.4 Asia Digital Companion Diagnostics Market Size by Region
9.4.1 Asia Digital Companion Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Digital Companion Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Digital Companion Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Myriad Genetic Laboratories, Inc.
11.1.1 Myriad Genetic Laboratories, Inc. Company Details
11.1.2 Myriad Genetic Laboratories, Inc. Business Overview
11.1.3 Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Introduction
11.1.4 Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2018-2023)
11.1.5 Myriad Genetic Laboratories, Inc. Recent Developments
11.2 Qiagen Manchester, Ltd.
11.2.1 Qiagen Manchester, Ltd. Company Details
11.2.2 Qiagen Manchester, Ltd. Business Overview
11.2.3 Qiagen Manchester, Ltd. Digital Companion Diagnostics Introduction
11.2.4 Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2018-2023)
11.2.5 Qiagen Manchester, Ltd. Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Digital Companion Diagnostics Introduction
11.3.4 Roche Revenue in Digital Companion Diagnostics Business (2018-2023)
11.3.5 Roche Recent Developments
11.4 Dako North America
11.4.1 Dako North America Company Details
11.4.2 Dako North America Business Overview
11.4.3 Dako North America Digital Companion Diagnostics Introduction
11.4.4 Dako North America Revenue in Digital Companion Diagnostics Business (2018-2023)
11.4.5 Dako North America Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Digital Companion Diagnostics Introduction
11.5.4 Abbott Revenue in Digital Companion Diagnostics Business (2018-2023)
11.5.5 Abbott Recent Developments
11.6 ICON plc
11.6.1 ICON plc Company Details
11.6.2 ICON plc Business Overview
11.6.3 ICON plc Digital Companion Diagnostics Introduction
11.6.4 ICON plc Revenue in Digital Companion Diagnostics Business (2018-2023)
11.6.5 ICON plc Recent Developments
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Details
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Digital Companion Diagnostics Introduction
11.7.4 Illumina, Inc Revenue in Digital Companion Diagnostics Business (2018-2023)
11.7.5 Illumina, Inc Recent Developments
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Details
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher Digital Companion Diagnostics Introduction
11.8.4 Thermo Fisher Revenue in Digital Companion Diagnostics Business (2018-2023)
11.8.5 Thermo Fisher Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Immunohistochemistry (IHC)
Table 4. Key Players of In Situ Hybridization (ISH)
Table 5. Key Players of Next Generation Sequencing (NGS)
Table 6. Global Digital Companion Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Digital Companion Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Digital Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Digital Companion Diagnostics Market Share by Region (2018-2023)
Table 10. Global Digital Companion Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Digital Companion Diagnostics Market Share by Region (2024-2033)
Table 12. Digital Companion Diagnostics Market Trends
Table 13. Digital Companion Diagnostics Market Drivers
Table 14. Digital Companion Diagnostics Market Challenges
Table 15. Digital Companion Diagnostics Market Restraints
Table 16. Global Digital Companion Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Digital Companion Diagnostics Revenue Share by Players (2018-2023)
Table 18. Global Top Digital Companion Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2022)
Table 19. Global Digital Companion Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Digital Companion Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Digital Companion Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Digital Companion Diagnostics, Product and Application
Table 23. Global Key Players of Digital Companion Diagnostics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Digital Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Digital Companion Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Digital Companion Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Digital Companion Diagnostics Revenue Market Share by Type (2024-2033)
Table 29. Global Digital Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Digital Companion Diagnostics Revenue Share by Application (2018-2023)
Table 31. Global Digital Companion Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Digital Companion Diagnostics Revenue Share by Application (2024-2033)
Table 33. North America Digital Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Digital Companion Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Digital Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Digital Companion Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Digital Companion Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Digital Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Digital Companion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Digital Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Digital Companion Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Digital Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Digital Companion Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Digital Companion Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Digital Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Digital Companion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Digital Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Digital Companion Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Digital Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Digital Companion Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Digital Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Digital Companion Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Digital Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Digital Companion Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Digital Companion Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Digital Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Digital Companion Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Digital Companion Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 65. Myriad Genetic Laboratories, Inc. Company Details
Table 66. Myriad Genetic Laboratories, Inc. Business Overview
Table 67. Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Product
Table 68. Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 69. Myriad Genetic Laboratories, Inc. Recent Developments
Table 70. Qiagen Manchester, Ltd. Company Details
Table 71. Qiagen Manchester, Ltd. Business Overview
Table 72. Qiagen Manchester, Ltd. Digital Companion Diagnostics Product
Table 73. Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 74. Qiagen Manchester, Ltd. Recent Developments
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Digital Companion Diagnostics Product
Table 78. Roche Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Roche Recent Developments
Table 80. Dako North America Company Details
Table 81. Dako North America Business Overview
Table 82. Dako North America Digital Companion Diagnostics Product
Table 83. Dako North America Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Dako North America Recent Developments
Table 85. Abbott Company Details
Table 86. Abbott Business Overview
Table 87. Abbott Digital Companion Diagnostics Product
Table 88. Abbott Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 89. Abbott Recent Developments
Table 90. ICON plc Company Details
Table 91. ICON plc Business Overview
Table 92. ICON plc Digital Companion Diagnostics Product
Table 93. ICON plc Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 94. ICON plc Recent Developments
Table 95. Illumina, Inc Company Details
Table 96. Illumina, Inc Business Overview
Table 97. Illumina, Inc Digital Companion Diagnostics Product
Table 98. Illumina, Inc Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 99. Illumina, Inc Recent Developments
Table 100. Thermo Fisher Company Details
Table 101. Thermo Fisher Business Overview
Table 102. Thermo Fisher Digital Companion Diagnostics Product
Table 103. Thermo Fisher Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 104. Thermo Fisher Recent Developments
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Digital Companion Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In Situ Hybridization (ISH) Features
Figure 6. Next Generation Sequencing (NGS) Features
Figure 7. Global Digital Companion Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Digital Companion Diagnostics Market Share by Application: 2022 VS 2033
Figure 9. Breast Cancer Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Colorectal Cancer Case Studies
Figure 13. Infectious Disease Case Studies
Figure 14. Others Case Studies
Figure 15. Digital Companion Diagnostics Report Years Considered
Figure 16. Global Digital Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Digital Companion Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Digital Companion Diagnostics Market Share by Region: 2022 VS 2033
Figure 19. Global Digital Companion Diagnostics Market Share by Players in 2022
Figure 20. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2022
Figure 22. North America Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Digital Companion Diagnostics Market Share by Type (2018-2033)
Figure 24. North America Digital Companion Diagnostics Market Share by Application (2018-2033)
Figure 25. North America Digital Companion Diagnostics Market Share by Country (2018-2033)
Figure 26. United States Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Digital Companion Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe Digital Companion Diagnostics Market Share by Type (2018-2033)
Figure 30. Europe Digital Companion Diagnostics Market Share by Application (2018-2033)
Figure 31. Europe Digital Companion Diagnostics Market Share by Country (2018-2033)
Figure 32. Germany Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China Digital Companion Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China Digital Companion Diagnostics Market Share by Type (2018-2033)
Figure 40. China Digital Companion Diagnostics Market Share by Application (2018-2033)
Figure 41. Asia Digital Companion Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia Digital Companion Diagnostics Market Share by Type (2018-2033)
Figure 43. Asia Digital Companion Diagnostics Market Share by Application (2018-2033)
Figure 44. Asia Digital Companion Diagnostics Market Share by Region (2018-2033)
Figure 45. Japan Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America Digital Companion Diagnostics Market Share by Country (2018-2033)
Figure 55. Brazil Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries Digital Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Myriad Genetic Laboratories, Inc. Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 62. Qiagen Manchester, Ltd. Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 63. Roche Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 64. Dako North America Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 65. Abbott Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 66. ICON plc Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 67. Illumina, Inc Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 68. Thermo Fisher Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed